Literature DB >> 2403858

Interferon inducers increase O6-alkylguanine-DNA alkyltransferase in the rat liver.

R Bertini1, P Coccia, P Pagani, C Marinello, M Salmona, M D'Incalci.   

Abstract

We investigated whether treatment with the interferon inducer polyinosinic-polycytidylic acid and other cytokines (interleukin-1, tumor necrosis factor) or the cytokine inducer lipopolysaccharide modified O6-alkylguanine-DNA alkyltransferase (AT) in rat liver. AT levels were determined in liver extracts using N-[3H]methyl-N-nitrosourea alkylated calf thymus DNA as substrate and an HPLC procedure to measure O6-methylguanine. Doses as low as 0.1 mg/kg i.p. of polyinosinic-polycytidylic acid caused a highly significant increase (P less than 0.01) in AT levels in the liver, evident either 24 or 48 h after treatment. Lipopolysaccharide at the dose of 80 micrograms/kg i.p. also induced AT whereas interleukin-1 (60 micrograms/kg) or tumor necrosis factor (60 micrograms/kg) were inactive. Treatment with human recombinant interferon alpha A/D caused a highly significant increase in AT levels, thus confirming the hypothesis that interferon was probably responsible for the observed effect. These results suggest a link between the immune response and DNA repair mechanisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403858     DOI: 10.1093/carcin/11.1.181

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  2 in total

1.  O6-Alkylguanine-DNA alkyltransferase content in synchronised human cancer cells.

Authors:  P Coccia; S Sen; E Erba; P Pagani; C Marinello; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  MHC-associated immunopotentiation affects the embryo response to teratogens.

Authors:  A Torchinsky; A Fein; H J Carp; V Toder
Journal:  Clin Exp Immunol       Date:  1994-12       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.